BridgeMD
New treatment option for Functioanl Dyspepsia
Official title Meu-cinn for Gastric Mucosal Health in Adults With Functional Dyspepsia
ClinicalTrials.gov ID: NCT06630455
What this study is testing
- What it's testing
- This clinical trial aims to determine whether Meu-cinn promotes gastric mucosal health in adults with functional dyspepsia and to assess its safety. The main questions are: Does Meu-cinn promote gastric mucosal health in participants?
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 70. Healthy volunteers may be eligible.
You may be able to join if
- Rome IV-based functional dyspepsia-
You likely can't join if
- Patients with gastrointestinal symptoms requiring immediate drug treatment.
- Individuals with a history of hypersecretory gastric disorders like Zollinger-Ellison syndrome.
- Individuals who received Helicobacter pylori eradication therapy within 4 weeks prior to the trial.
- Individuals who have taken nonsteroidal anti-inflammatory drugs, steroids, antibiotics, aspirin, antithrombotic agents, or acid suppressants within...
- Individuals with a history of upper gastrointestinal surgery, stricture, bleeding, or procedures like esophageal dilation or mucosal resection within...
- Individuals with gastric ulcers (active or healing), duodenal ulcers (active or healing), reflux esophagitis (LA grade A or higher), or malignant...
See the full eligibility criteria
- Rome IV-based functional dyspepsia-
- Patients with gastrointestinal symptoms requiring immediate drug treatment.
- Individuals with a history of hypersecretory gastric disorders like Zollinger-Ellison syndrome.
- Individuals who received Helicobacter pylori eradication therapy within 4 weeks prior to the trial.
- Individuals who have taken nonsteroidal anti-inflammatory drugs, steroids, antibiotics, aspirin, antithrombotic agents, or acid suppressants within the last month.
- Individuals with a history of upper gastrointestinal surgery, stricture, bleeding, or procedures like esophageal dilation or mucosal resection within the last year.
- Individuals with gastric ulcers (active or healing), duodenal ulcers (active or healing), reflux esophagitis (LA grade A or higher), or malignant tumors identified within the last 6 months through endoscopy.
- Patients with uncontrolled hypertension (resting BP ≥160/100 mmHg).
- Patients with uncontrolled diabetes (fasting glucose ≥160 mg/dL).
- Individuals with creatinine levels ≥ 2 times the upper limit of normal at the research institution.
- Individuals with aspartate aminotransferase or alanine aminotransferase levels ≥ 2 times the upper limit of normal at the research institution.
- Alcohol abusers.
- Individuals taking medications for psychiatric disorders (except those taking intermittent medication for sleep disorders).
- Pregnant or breastfeeding women or those planning to become pregnant during the clinical trial period.
- Individuals with allergies to any components of the study foods.
- Individuals who participated in or plan to participate in another drug clinical trial within the last month.
- Individuals deemed unsuitable for the study by the investigator for other reasons.
The study team makes the final eligibility decision.
Where it's taking place
- Yangsan, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years to 70 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Yangsan, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.